http:\/\/www.trend-online.com\/ansa\/fta159022\/#sthash.bO7qU0mW.dpuf<\/a> <\/p>\n<\/span><\/p>\n
Generics: 4.2bn $ merger for Indian companies Sun Pharma and RanbaxyOpening in progress in Mumbai (+3%)<\/span><\/span><\/p>\n<\/span><\/p>\n
Shares Sun Pharma are in progress in Mumbai (+3.2%) following the announcement by the Indian generics maker of its acquisition of rival Ranbaxy Laboratories in an all-equity deal combining two companies with combined 4.2 billion dollars in revenues (the value of the deal, communicates Sun Pharma, is instead 3.2 billion). Ranbaxy, India's leading drugmaker, has long been in crisis due to problems with the US authorities. Meanwhile, in Tokyo, Daiichi Sankyo shares opened up 3.5% with investors celebrating the exit of the Japanese pharmaceutical group from Ranbaxy, in which it had acquired the majority stake in 2008, only to then be forced to balance $3.8 billion in losses related to the deal<\/span><\/span>. ","protected":false},"excerpt":{"rendered":" L’Alta corte dell’Andhra Pradesh High Court ha sollevato sabato il blocco temporaneo al takeover da 3,2 miliardi di dollari del produttore di farmaci generici Sun Pharmaceutical Industries da parte di Ranbaxy Laboratories. L’Alta corte dell’Andhra Pradesh High Court ha sollevato sabato il blocco temporaneo al takeover da 3,2 miliardi di dollari del produttore di …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-18037","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=18037"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18037\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=18037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=18037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=18037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}